Pyruvate Dehydrogenase Complex Deficiency Caused by Ubiquitination and Proteasome-mediated Degradation of the E1β Subunit

作者: Zongchao Han , Li Zhong , Arun Srivastava , Peter W. Stacpoole

DOI: 10.1074/JBC.M704748200

关键词:

摘要: Congenital deficiencies of the human pyruvate dehydrogenase (PDH) complex are considered to be due loss function mutations in one component enzymes. Here we describe a case PDH deficiency associated with E1β subunit (PDHB) gene. The clinical phenotype patient was consistent reported cases deficiency. Cultured skin fibroblasts demonstrated 55% reduction activity and markedly decreased immunoreactivity for PDHB protein, compared healthy controls. Surprisingly, nucleotide sequence analyses cDNAs corresponding E1α (PDHA1) genes revealed no pathological mutations. Moreover, relative expression level mRNA rates transcription translation gene were normal. However, PDC could restored cells from this following treatment MG132, specific proteasome inhibitor, normal levels detected MG132-treated cells. Similar results obtained Tyr-phostin 23 (Tyr23), inhibitor epidermal growth factor receptor-protein-tyrosine kinase (EGFR-PTK), which also protein those subjects or patients PDHA1 index patient's contained high basal EGFR-PTK that correlated ubiquitination cellular proteins, although total EGFR similar Elα-deficient subjects. These data indicate our involves post-translational modification EGFR-PTK-mediated tyrosine phosphorylation leads enhanced followed by proteasome-mediated degradation. They provide novel mechanism accounting congenital perhaps other inborn errors metabolism.

参考文章(34)
Naoko Minegishi, Norio Suzuki, Yukie Kawatani, Ritsuko Shimizu, Masayuki Yamamoto, Rapid turnover of GATA‐2 via ubiquitin‐proteasome protein degradation pathway Genes to Cells. ,vol. 10, pp. 693- 704 ,(2005) , 10.1111/J.1365-2443.2005.00864.X
Kristi Jennings, Takako Miyamae, Russell Traister, Anthony Marinov, Shigeki Katakura, Dawn Sowders, Bruce Trapnell, James M. Wilson, Guangping Gao, Raphael Hirsch, Proteasome Inhibition Enhances AAV-Mediated Transgene Expression in Human Synoviocytes in Vitro and in Vivo Molecular Therapy. ,vol. 11, pp. 600- 607 ,(2005) , 10.1016/J.YMTHE.2004.10.020
A. Lewis Farr, Oliver H. Lowry, Rose J. Randall, Nira J. Rosebrough, Protein Measurement with the Folin Phenol Reagent Journal of Biological Chemistry. ,vol. 193, pp. 265- 275 ,(1951)
Aviv Gazit, Pnina Yaish, Chaim Gilon, Alexander Levitzki, Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors. Journal of Medicinal Chemistry. ,vol. 32, pp. 2344- 2352 ,(1989) , 10.1021/JM00130A020
Françoise Fouque, Michelle Brivet, Audrey Boutron, Christiane Vequaud, Cécile Marsac, Marie-Thérèse Zabot, Chantal Benelli, Differential Effect of DCA Treatment on the Pyruvate Dehydrogenase Complex in Patients with Severe PDHC Deficiency Pediatric Research. ,vol. 53, pp. 793- 799 ,(2003) , 10.1203/01.PDR.0000057987.46622.64
RuthM. Brown, RosemaryA. Head, IvanI. Boubriak, JamesV. Leonard, NeilH. Thomas, GarryK. Brown, Mutations in the gene for the E1β subunit: a novel cause of pyruvate dehydrogenase deficiency Human Genetics. ,vol. 115, pp. 123- 127 ,(2004) , 10.1007/S00439-004-1124-8
Katrine M. Andersen, Kay Hofmann, Rasmus Hartmann-Petersen, Ubiquitin-binding proteins: similar, but different. Essays in Biochemistry. ,vol. 41, pp. 49- 67 ,(2005) , 10.1042/EB0410049
Cecile M Pickart, Back to the Future with Ubiquitin Cell. ,vol. 116, pp. 181- 190 ,(2004) , 10.1016/S0092-8674(03)01074-2
Anthony C. Bishop, Kevan M. Shokat, Acquisition of Inhibitor-Sensitive Protein Kinases through Protein Design Pharmacology & Therapeutics. ,vol. 82, pp. 337- 346 ,(1999) , 10.1016/S0163-7258(98)00060-6
Rosemary A. Head, Ruth M. Brown, Zarazuela Zolkipli, Raveen Shahdadpuri, Mary D. King, Peter T. Clayton, Garry K. Brown, Clinical and genetic spectrum of pyruvate dehydrogenase deficiency: dihydrolipoamide acetyltransferase (E2) deficiency. Annals of Neurology. ,vol. 58, pp. 234- 241 ,(2005) , 10.1002/ANA.20550